General trial characteristics

First author Publish year Citation: Contact author detail:

Eligibility

1. Is the study an RCT? 2. High‐risk Women? 3. How OHSS defined? 4. Administration of cabergoline? Decision: If all replies yes means include, otherwise exclude

Characteristics of the included studies

Risk of bias

sequence generation (low, high or unclear) allocation concealment (low, high or unclear) blinding of participants (low, high or unclear) personnel and outcome assessors (low, high or unclear) incomplete outcome data, and selective outcome reporting (low, high or unclear)

Methods

Inclusion criteria: Exclusion criteria:

Participants

Total number: Diagnosis criteria: Age (mean ± SD): treat group vs control group: BMI (mean ± SD): treat group vs control group: Duration of infertility: Causes of infertility:

Interventions

Treat group:(dose, administration of drug, duration of treatment) Control group (placebo or no intervention):

Outcomes

Incidence of moderate and / or severe OHSS Incidence of early and / or late OHSS Live Birth rate Any other adverse effects of the treatment Miscarriage rate Implantation rate Clinical pregnancy rate Multiple pregnancy rate

Results

Number of participants allocated to each intervention group. For each outcome of interest: Sample size. Missing participants*. Summary data for each intervention group (e.g. 2x2 table for dichotomous data). [Estimate of effect with confidence interval; P value]. [Subgroup analyses].

Miscellaneous

Funding source. Key conclusions of the study authors. Miscellaneous comments from the study authors. References to other relevant studies. Correspondence required. Miscellaneous comments by the review authors.  BMI: body mass index; OHSS: ovarian hyperstimulation syndrome; RCT: randomised controlled trial; SD: standard deviation.